Blackstone Inc. and TPG Inc. are in advanced negotiations to acquire Hologic Inc. in a deal that could value the medical device maker at more than $17 billion including debt, according to people familiar with the matter.<\/p>\n
A transaction could be announced in the coming days, said the people, who asked not to be identified because the talks are private. The parties are currently discussing a price of above $75 a share, they said.<\/p>\n
Hologic shares jumped about 6 percent in late trading after Bloomberg reported on the discussions. They had closed 2 percent higher at $69.85 Friday in New York, giving the company a market value of about $15.5 billion.<\/p>\n
A final agreement hasn\u2019t been reached and the talks could still fall apart, the people said.<\/p>\n
Representatives of Blackstone and TPG declined to comment, as did a spokesperson for Marlborough, Massachusetts-based Hologic.<\/p>\n
Bloomberg News reported last month that the private equity firms had reengaged with the company\u2019s board.<\/p>\n
Hologic is focused on women\u2019s health, and develops diagnostic solutions for breast and cervical cancer, as well as infectious diseases like COVID-19. Any deal for the company could end up becoming one of the biggest private equity takeovers globally this year, according to data compiled by Bloomberg.<\/p>\n
With assistance from Manuel Baigorri.<\/p>\n","protected":false},"excerpt":{"rendered":"Blackstone Inc. and TPG Inc. are in advanced negotiations to acquire Hologic Inc. in a deal that could…\n","protected":false},"author":2,"featured_media":134424,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[275],"tags":[19360,15852,9521,10006,207,80349,6738,80350,18,810,1729,846,135,475,474,19,11995,17,50619,18113,12443,80351,22234,80352,3070,19365,19366,107,1543],"class_list":["post-134423","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-american","tag-americas","tag-building","tag-buildings","tag-business-news","tag-corporate-finance","tag-earnings","tag-earns","tag-eire","tag-exteriors","tag-finance","tag-financial","tag-health","tag-health-care","tag-healthcare","tag-ie","tag-industries","tag-ireland","tag-logo","tag-north-american","tag-sign","tag-signage","tag-signs","tag-stands","tag-u-s","tag-u-s-a","tag-united-states-of-america","tag-us","tag-usa"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/134423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=134423"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/134423\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/134424"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=134423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=134423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=134423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}